OpenAlex
PricingAboutJobs
Log inGet started
Author

Michael Schulewski

Institution: Rutgers, The State University of New Jersey
Observed institution: Rutgers, The State University of New Jersey
ORCID: 0009-0006-7676-907X
Observed ORCID: 0009-0006-7676-907X
OpenAlex ID: A5146670656
Concurrent Gabapentin and Dihydropyridine Calcium Channel Blocker Use and Risk of Incident Dementia: An Active-Comparator Cohort Study
2026 · James W. Green, Luciana Mascarenhas Fonseca, et al. · medRxiv · 2
PDF
Do Cognitive Symptoms Improve When Gabapentin and Dihydropyridine Calcium Channel Blocker Therapy Are Stopped? A Self-Controlled Case Series
2026 · James W. Green, Joshua Kaplan, et al. · medRxiv · 1
PDF
Letter to the Editor for “Evaluating Pharmacogenomic Prescription Data in the Military Health System”: Medication-Induced CYP2D6 Inhibition Reveals a Screening Gap in Proxy-Defined Ibogaine Candidates
2026 · James Green, Paul Hartin, et al. · Military Medicine
Does Medication Order Matter? Incident Dementia Risk When Gabapentin Is Added to Prior Dihydropyridine Calcium Channel Blocker Therapy: An Active-Comparator Cohort Study in Hypertensive Adults
2026 · James W. Green, Joshua Kaplan, et al. · medRxiv
Chronic Kidney Disease Amplifies Gabapentin-Associated Dementia Risk in Non-Dialysis Patients: Findings Consistent with a Renal Pharmacokinetic Vulnerability
2026 · James Green, Laura D. Byham-Gray, et al. · medRxiv
PDF
Works count: 5
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security